Sanofi (Genzyme) Plans To Appeal FDA Decision to Not Approve Lemtrada For Treatment of Multiple-Sclerosis
Back in 2012 the FDA did approve another drug from Genzyme, who is owned by Sanofi for the treatment of multiple-sclerosis and the current d...
